STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
5
Codes C/M, not in net · $1.8M priced
What the filings say about DORM
Insiders, 180 days
-$611.3K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$611.3K
2 notices
Dorman Products insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Dorman Products, Inc. insiders sold a net $611.3K of stock across 113 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Nobody has filed for crossing 5%. That is a fact, not missing data.
DORM planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Long Donna M.
Filed 2026-08-17
$99.2K
Bowen Gregory C.
Filed 2026-08-05
$512.0K
Executive pay vs shareholder return · Mr. Olsen
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$4.2M
$2.8M
$1.2M
+11%
+4%
2022
$3.1M
$1.0M
$1.1M
+8%
+8%
2021
$3.4M
$4.2M
$1.3M
+42%
+39%
2020
$2.2M
$2.7M
$1.2M
+19%
+14%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $611.3K sold by insiders over 180 days, $611.3K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.2B
four quarters, 2025-06-29 to 2026-06-27
Revenue, TTM DORM
FY Dec 2025
$2.1B
FY Dec 2024
$2.0B
FY Dec 2023
$1.9B
FY Dec 2022
$1.7B
FY Dec 2021
$1.3B
Jun 2026
$544.6M
Mar 2026
$528.8M
Dec 2025
$537.9M
Sep 2025
$543.7M
Jun 2025
$541.0M
Mar 2025
$507.7M
Dec 2024
$533.8M
Sep 2024
$503.8M
At each fiscal year end
Single quarter
Net margin, TTM
+10.2%
net income over revenue, 2025-06-29 to 2026-06-27
Net margin, TTM DORM
FY Dec 2025
+9.6%
FY Dec 2024
+9.5%
FY Dec 2023
+6.7%
FY Dec 2022
+7.0%
FY Dec 2021
+9.8%
Jun 2026
+16.1%
Mar 2026
+8.2%
Dec 2025
+2.1%
Sep 2025
+14.1%
Jun 2025
+10.9%
Mar 2025
+11.3%
Dec 2024
+10.2%
Sep 2024
+11.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$214.2M
operating cash flow minus capex, 2025-06-29 to 2026-06-27
Free cash flow, TTM DORM
FY Dec 2025
$75.7M
FY Dec 2024
$191.6M
FY Dec 2023
$164.8M
FY Dec 2022
$3.8M
FY Dec 2021
$80.5M
Jun 2026
$143.5M
Mar 2026
$35.3M
Dec 2025
$33.5M
Sep 2025
$1.8M
Jun 2025
$98.0K
Mar 2025
$40.3M
Dec 2024
$63.2M
Sep 2024
$35.7M
At each fiscal year end
Single quarter
Debt to equity
0.29x
long-term 2026-06-27 plus current 2026-06-27; equity 2026-06-27
Debt to equity DORM
FY Dec 2025
0.30x
FY Dec 2024
0.36x
FY Dec 2023
0.41x
FY Dec 2022
0.47x
FY Dec 2021
0.00x
Jun 2026
0.29x
Mar 2026
0.30x
Dec 2025
0.30x
Sep 2025
0.31x
Jun 2025
0.33x
Mar 2025
0.35x
Dec 2024
0.36x
Sep 2024
0.38x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.57x
TTM operating cash flow over long-term 2026-06-27 plus current 2026-06-27
Cash flow to debt DORM
FY Dec 2025
0.26x
FY Dec 2024
0.49x
FY Dec 2023
0.43x
FY Dec 2022
0.08x
FY Dec 2021
n/a
Jun 2026
0.57x
Mar 2026
0.24x
Dec 2025
0.26x
Sep 2025
0.31x
Jun 2025
0.38x
Mar 2025
0.50x
Dec 2024
0.49x
Sep 2024
0.46x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+15.0%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on equity DORM
FY Dec 2025
+14.7%
FY Dec 2024
+15.4%
FY Dec 2023
+11.7%
FY Dec 2022
+12.3%
FY Dec 2021
+14.7%
Jun 2026
+15.0%
Mar 2026
+13.6%
Dec 2025
+14.7%
Sep 2025
+18.2%
Jun 2025
+17.4%
Mar 2025
+17.1%
Dec 2024
+15.4%
Sep 2024
+15.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+8.8%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on assets DORM
FY Dec 2025
+8.3%
FY Dec 2024
+8.1%
FY Dec 2023
+5.6%
FY Dec 2022
+6.1%
FY Dec 2021
+9.1%
Jun 2026
+8.8%
Mar 2026
+7.8%
Dec 2025
+8.3%
Sep 2025
+10.1%
Jun 2025
+9.5%
Mar 2025
+9.2%
Dec 2024
+8.1%
Sep 2024
+8.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.8%
operating income after a 26.0% effective tax rate, over long-term 2026-06-27 plus current 2026-06-27 plus average of 2025-06-28 and 2026-06-27 minus cash
Return on invested capital DORM
FY Dec 2025
+12.5%
FY Dec 2024
+13.2%
FY Dec 2023
+10.7%
FY Dec 2022
+9.3%
FY Dec 2021
+16.9%
Jun 2026
+12.8%
Mar 2026
+11.5%
Dec 2025
+12.5%
Sep 2025
+15.1%
Jun 2025
+14.4%
Mar 2025
+14.3%
Dec 2024
+13.2%
Sep 2024
+13.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+15.5%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-06-27 minus current liabilities
Return on capital employed DORM
FY Dec 2025
+15.5%
FY Dec 2024
+16.2%
FY Dec 2023
+12.6%
FY Dec 2022
+12.8%
FY Dec 2021
+18.0%
Jun 2026
+15.5%
Mar 2026
+14.3%
Dec 2025
+15.5%
Sep 2025
+18.5%
Jun 2025
+17.7%
Mar 2025
+17.4%
Dec 2024
+16.2%
Sep 2024
+16.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
17.28x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-29 to 2026-06-27
P/E, trailing DORM
FY Dec 2025
18.55x
FY Dec 2024
21.07x
FY Dec 2023
20.34x
FY Dec 2022
21.06x
FY Dec 2021
25.77x
Jun 2026
18.66x
Mar 2026
16.86x
Dec 2025
18.55x
Sep 2025
19.34x
Jun 2025
16.91x
Mar 2025
17.32x
Dec 2024
21.07x
Sep 2024
18.99x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$4.0B
market value at close 2026-10-26 on 2026-07-30 shares, plus long-term 2026-06-27 plus current 2026-06-27, minus cash 2026-06-27
Enterprise value DORM
FY Dec 2025
$4.2B
FY Dec 2024
$4.4B
FY Dec 2023
$3.1B
FY Dec 2022
$3.0B
FY Dec 2021
$3.3B
Jun 2026
$4.3B
Mar 2026
$3.6B
Dec 2025
$4.2B
Sep 2025
$5.1B
Jun 2025
$4.2B
Mar 2025
$4.1B
Dec 2024
$4.4B
Sep 2024
$3.9B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.8%
TTM free cash flow over market value at close 2026-10-26
FCF yield DORM
FY Dec 2025
+2.0%
FY Dec 2024
+4.8%
FY Dec 2023
+6.3%
FY Dec 2022
+0.1%
FY Dec 2021
+2.4%
Jun 2026
+5.3%
Mar 2026
+2.2%
Dec 2025
+2.0%
Sep 2025
+2.2%
Jun 2025
+3.7%
Mar 2025
+5.2%
Dec 2024
+4.8%
Sep 2024
+5.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -2%, PEG needs growth
PEG, trailing DORM
FY Dec 2025
2.33x
FY Dec 2024
0.42x
FY Dec 2023
3.00x
FY Dec 2022
n/a
FY Dec 2021
1.02x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
2.33x
Sep 2025
0.56x
Jun 2025
0.49x
Mar 2025
0.43x
Dec 2024
0.42x
Sep 2024
0.20x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
DORM ranks highest on profitability (77th percentile) and financial health (69th), and lowest on insider conviction (21st), among Autos peers.
Profitability
77
Inputs
Return on equity+15.0% · 82 pct, sector of 51
Return on assets+8.8% · 85 pct, sector of 61
Return on invested capital+12.8% · 54 pct, universe of 1,069
Return on capital employed+15.5% · 85 pct, sector of 48
Financial health
69
Inputs
Debt to equity0.29x · 60 pct, sector of 63
Cash flow to debt0.57x · 78 pct, sector of 52
Growth
57
Inputs
Revenue growth, YoY+6.0% · 57 pct, sector of 78
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
21
Inputs
Net Form 4 buying (codes P and S), 180d-$611K · 42 pct, sector of 46
Insider buyers, 180d0 · 0 pct, sector of 47
Risk and compliance
22
Inputs
Short interest, % of float+6.3% · 39 pct, sector of 90
Recalls per $1B revenue, 3y0.47 per $1B · 25 pct, sector of 54
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+63.3% · 2 pct, sector of 58
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
DORM filings, in plain words
Are Dorman Products insiders buying or selling DORM?
In the 180 days to 2026-10-28, Dorman Products insiders were net sellers, a net $611.3K across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of DORM?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $611.3K of stock; the latest, by Long Donna M., was filed 2026-08-17.
Read the full summary
In the 180 days to 2026-10-28, Dorman Products insiders were net sellers of DORM, a net $611.3K across purchases and sales reported on Form 4 by 2 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $611.3K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.